Dr. John Cush RheumNow
3 years 10 months ago
73-87% of autoimmune (RA, SLE, UCTD, APL) pts used HCQ during pregnancy. HCQ significantly reduced pre-eclampsia (20% vs 9%), early-onset pre-eclampsia (8% vs 2.5%), 2nd/3rd trimester pregnancy loss (3% vs. 0.6%) https://t.co/CF5ivHeCmY https://t.co/CYqaCCuZJz
Dr. John Cush RheumNow
3 years 10 months ago
Fever, FROST, & Pericarditis
Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK.
https://t.co/IFxocGkOxJ https://t.co/OzoS248ZRK
Dr. John Cush RheumNow
3 years 10 months ago
Review of the Rheumatic causes of Pericarditis and their management. Causes: SLE, RA, MCTD, Myositis, EGPA, GPA, IgG4-rel Dz, FMF, TRAPS, CAPS, AOSD, JIA, Sarcoidosis, Kawasakis, GCA, Takayasu's https://t.co/MQmkUe4Yey https://t.co/FSfrznoeBe
Dr. John Cush RheumNow
3 years 10 months ago
JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD
The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected.
https://t.co/LWHKO0gRu4 https://t.co/i2IOLcAgt3
Dr. John Cush RheumNow
3 years 10 months ago
New download available-GCA and PMR New Drugs
https://t.co/7Y4g6zvTQx. https://t.co/ZfVO0SRVuL
Dr. John Cush RheumNow
3 years 10 months ago
CXCL5 Therapy in Lupus?
A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus, or lupus, an incurable autoimmune disease.
https://t.co/B82Xq5FFNJ. https://t.co/ba2nlFuDsI
Dr. John Cush RheumNow
3 years 10 months ago
Low dose steroids can negatively impact bone health
Dr. Janet Pope discusses abstract L01 presented at ACR22.
https://t.co/eBGMza9tWE https://t.co/wACnLTxATu
Dr. John Cush RheumNow
3 years 10 months ago
The First Head to Head trial in Axial SpA
Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study
https://t.co/RgwKRJwgoS https://t.co/6LxOURICiE
Dr. John Cush RheumNow
3 years 10 months ago
Marginal Benefit with Diet and Exercise in Obese Knee Osteoarthritis Patients
The easiest intervention for knee osteoarthritis (diet and exercise) is also the most difficult for many patients; but do these work?
https://t.co/s4Gzmh2gGZ https://t.co/aZORTMtCvs
Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK".
Nature Reviews Rheumatology features a review of three notable papers that address the impact of SARS-CoV-2 vaccination on people with inflammatory rheumatic disease.
Dr. John Cush RheumNow
3 years 10 months ago
Get the Skinny on Bimekizumab in PsA
Dr. Janet Pope discusses abstract presented at #ACR22.
https://t.co/FKFARxQ2fa https://t.co/wSyXeSHII3
Dr. John Cush RheumNow
3 years 10 months ago
During 2021–22 FLU season, 6% of hosp pedi-influenza pts had SARS-CoV-2 coinfection; these required more respiratory support. Risk of influenza death augmented by not recv vaccination (flu or covid), no antiviral Rx, comorbidities & coinfx w/COVID https://t.co/bfjeClHflW https://t.co/YTOEnNSQQN
Dr. John Cush RheumNow
3 years 10 months ago
Lupus Research Alliance announced 2022 Distinguished Innovator Award recipients:
- Hongbo Chi, PhD, Exploring Metabolism of Follicular Helper T Cells & Lupus Progression
- Joseph Craft, MD: Processes Enabling T Cells to Be Destructive in Lupus Nephritis
https://t.co/yI2NlCHaBi https://t.co/fevBTkaxCY

